Latest News & Features
Africa
There is some debate about whether the ‘patent cliff’ or the need to innovate is driving M&A activity in the pharmaceutical industry, where billions of dollars have been spent in the past few years, as LSIPR finds out. 10 October 2016
Americas
Teva and South Korean biopharmaceutical company Celltrion have entered into an exclusive partnership to commercialise two of Celltrion’s biosimilars in the US and Canada. 7 October 2016
Americas
Hedge fund manager Kyle Bass has lost a patent case against Shire over the drug Lialda. 7 October 2016
Americas
Roche is working hard to fight cancer and lead the way in personalised medicine, while at the same time dealing with patenting, litigation and other challenges, says chief IP counsel Mike Young in an interview with LSIPR. 7 October 2016
Big Pharma
On December 7, LSIPR will be hosting the Life Sciences Patents Network Europe 2016 at the Bloomsbury Hotel in London. Here we preview the main talking points. 7 October 2016
Americas
Amgen has filed complaints against Indian pharmaceutical companies Dr Reddy’s and Ajanta Pharma for allegedly infringing a patent centring on its drug Sensipar. 6 October 2016
Big Pharma
Teva has agreed to sell certain assets and operations of Actavis Generics in the UK and Ireland to Accord Healthcare, a subsidiary of Indian generics firm Intas Pharmaceuticals. 6 October 2016
Europe
Law firm McDermott Will & Emery has appointed Henrik Holzapfel as a partner in its Düsseldorf, Germany office. 6 October 2016
Americas
Martin Shkreli and Jim Tananbaum were selected in the LSIPR 50 2016 publication for their influence on the life sciences industry. Shkreli and Tananbaum were featured in the investment section, as LSIPR reports. 5 October 2016
Americas
Robert Nelsen and Bryan Roberts were selected in the LSIPR 50 2016 publication for their influence on the life sciences industry. Nelsen and Roberts were featured in the investment section, as LSIPR reports. 5 October 2016